Beryl Drugs Q2 Results
- BSE: 524606
- NSE: -
- ISIN: INE415H01017
- Sector: Biotechnology & Drugs
BSE
33.1
0.57 (1.75%)
0.57 (1.75%)Volume212.00
Updated: Tue 26 Nov, 2024 | 09:07:13
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Beryl Drugs Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 23 | Jun 23 | QoQ Comp |
|---|---|---|---|
| Total Revenue | 8.03 | 8.11 | -% |
| Selling/ General/ Admin Expenses Total | 0.45 | 0.44 | -% |
| Depreciation/ Amortization | 0.29 | 0.28 | -% |
| Other Operating Expenses Total | 3.59 | 3.01 | -% |
| Total Operating Expense | 7.66 | 7.32 | -% |
| Operating Income | 0.36 | 0.79 | -% |
| Net Income Before Taxes | 0.33 | 0.73 | -% |
| Net Income | 0.27 | 0.53 | -% |
| Diluted Normalized EPS | 0.54 | 1.05 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment status out. GMP, how to check status online
2 min read06:38 AM IST - Markets
02Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read25 Nov 2024 - Markets
03C2C Advanced Systems IPO Day 2: Check GMP, subscription status and other key details
2 min read25 Nov 2024